Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

BACKGROUND: Apolipoprotein D (ApoD) has been proposed as a predictor of breast cancer recurrence among estrogen receptor-positive (ER+), tamoxifen-treated patients. METHODS: We conducted a population-based case-control study nested in a population of 11,251 women aged 35–69 years at diagnosis with S...

Descripción completa

Detalles Bibliográficos
Autores principales: Klebaner, Daniella, Hamilton-Dutoit, Stephen, Ahern, Thomas, Crawford, Anatasha, Jakobsen, Thomas, Cronin-Fenton, Deirdre P., Damkier, Per, Janssen, Emiel, Kjaersgaard, Anders, Ording, Anne Gulbech, Søiland, Håvard, Sørensen, Henrik Toft, Lash, Timothy L., Hellberg, Ylva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354364/
https://www.ncbi.nlm.nih.gov/pubmed/28301514
http://dx.doi.org/10.1371/journal.pone.0171453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354364/
https://www.ncbi.nlm.nih.gov/pubmed/28301514
http://dx.doi.org/10.1371/journal.pone.0171453

Ejemplares similares